Notas del episodio
Phase 3 for rentosertib shifted to pulmonary fibrosis, where senescent fibroblasts drive the disease nobody's solved. If senescent cell clearance works here, you're validating a mechanism that rewrites how we think about progressive disease—and what it means for aging biology beyond the lab.

